Serial Number
86863341
Owner
Lazarex Cancer FoundationAttorney
Jean L. BatmanFirst Use Date
Jan 10, 2016
Filing Date
Dec 31, 2015
IMPACT IMPROVING PATIENT ACCESS TO CLINICAL TRIALS Trademark
Serial Number: 86863341 • Registration: 5219362
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Jean L. Batman LEGAL VENTURE COUNSEL, INC.
505 Montgomery St., 11th Fl.
SAN FRANCISCO, CA 94111
United States
Trademark Details
Filing Date
December 31, 2015
Registration Date
June 6, 2017
First Use Anywhere
January 10, 2016
First Use in Commerce
January 10, 2016
Published for Opposition
October 25, 2016
Goods & Services
Accepting and administering monetary charitable contributions; Charitable foundation services, namely, providing financial assistance for programs and services of others; Charitable foundation services, namely, providing financial support to cancer patients for participation in clinical trials; Charitable foundation services, namely, providing fundraising activities to support medical research and procedures for those in need; Charitable foundation services, namely, providing fundraising activities, funding, scholarships and/or financial assistance for cancer patient participation in clinical trials; Charitable fundraising; Charitable fundraising services by means of running and walking events; Charitable fundraising services by means of an entertainment event; Charitable services, namely, granting funds to schools
Charitable services, namely, mentoring of cancer patients in the field of clinical trials; Charitable services, namely, providing educational materials in the nature of websites, brochures, handouts, and advertising regarding clinical trials availability and admission criteria to cancer patients; Development and dissemination of printed educational materials of others in the field of cancer treatment, clinical trials, and early detection of cancer; Educational services, namely, conducting community outreach in the form of one-on-one counseling, workshops, and events for cancer patients in the fields of cancer treatment, clinical trials, and early detection of cancer; Educational services, namely, seminars and online programs providing data about cancer treatment and clinical trials and distribution of educational materials in connection therewith; Providing educational assessment services; Providing science educational mentoring services and programs
